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Breakdown of vascular barriers is a major complication of inflammatory diseases. Anucleate
platelets form blood-clots during thrombosis, but also play a crucial role in inflammation.
While spatio-temporal dynamics of clot formation are well characterized, the cell-biological
mechanisms of platelet recruitment to inflammatory micro-environments remain incomple-
tely understood. Here we identify Arp2/3-dependent lamellipodia formation as a prominent
morphological feature of immune-responsive platelets. Platelets use lamellipodia to scan for
fibrin(ogen) deposited on the inflamed vasculature and to directionally spread, to polarize
and to govern haptotactic migration along gradients of the adhesive ligand. Platelet-specific
abrogation of Arp2/3 interferes with haptotactic repositioning of platelets to microlesions,
thus impairing vascular sealing and provoking inflammatory microbleeding. During infection,
haptotaxis promotes capture of bacteria and prevents hematogenic dissemination, rendering
platelets gate-keepers of the inflamed microvasculature. Consequently, these findings iden-
tify haptotaxis as a key effector function of immune-responsive platelets.
https://doi.org/10.1038/s41467-020-19515-0 OPEN
1Medizinische Klinik und Poliklinik I, Klinikum der Ludwig-Maximilians-Universität, 81377 Munich, Germany. 2 DZHK (German Centre for Cardiovascular
Research), Partner Site Munich Heart Alliance, 80802 Munich, Germany. 3 Ludwig-Maximilians-Universität, 80799 Munich, Germany. 4Walter-Brendel-
Centre of Experimental Medicine, University Hospital, München, Germany. 5 Institute of Cardiovascular Physiology and Pathophysiology, Biomedical Center,
Planegg-Martinsried, Munich, Germany. 6Department of Otorhinolarynology, Ludwig-Maximilians-Universität Munich, Munich, Germany. 7 Department of
Cell Biology, Johns Hopkins University School of Medicine, 855 North Wolfe Street, Baltimore, MD 21205, USA. 8 Institute of Science and Technology (IST)
Austria, 3400 Klosterneuburg, Austria. 9 Institute of Experimental Biomedicine I, University Hospital and Rudolf Virchow Center, Würzburg, Germany.
✉email: steffen.massberg@med.uni-muenchen.de; florian.gaertner@ist.ac.at









C irculating platelets are anucleate cell fragments releasedfrom large precursor cells termed megakaryocytes1. Pla-telets preserve vascular integrity through hemostatic clot
formation, but they are also central coordinators of vascular
inflammation and host defense by directly fighting pathogenic
invaders and by orchestrating leukocyte trafficking2–6. Inflam-
mation triggers a canonical platelet effector program distinct
from classical hemostasis and thrombosis. While clotting requires
platelets to engage in multicellular aggregation and retraction of
the thrombus, they mainly act as individual cells when encoun-
tering inflammation7–10. Under inflammatory conditions, single
platelets occupy strategic positions where they serve as landing
pads for leukocytes and aid in intravascular crawling and extra-
vasation. At the same time, platelets help to limit inflammatory
collateral damage. In particular, they play a central role in plug-
ging holes in the vasculature caused by transmigrating leuko-
cytes2,8,11. This ability of single platelets to seal inflammatory
microlesions smaller than the diameter of a cell is essential to
prevent severe bleedings in inflammation, infection, and can-
cer12,13. For efficient sealing of microlesions, individual platelets
need to detect defects that are few μm2 in size in an endothelial
layer that covers a surface of >1000 m2 in humans.
Effective recruitment of inflammation-responsive platelets to
microlesions therefore requires a high degree of precision, sug-
gesting a spatiotemporally tightly coordinated rather than sto-
chastic process.
Directional migration is a fundamental cell-biological process
enabling cells to locomote along guidance cues to autonomously
change position during embryonic development, cancer dis-
semination, and inflammation14. Directional locomotion does not
rely on the presence of the cell nucleus, as recently demonstrated
by enucleation of fibroblasts and endothelial cells in vitro15.
Platelets are a unique physiological model of anucleate cell
migration in vivo and their ability to migrate was shown to boost
inflammation in sepsis16. However, whether platelet migration is
directionally instructed by specific guidance cues from the
inflammatory microenvironment and may target platelets to
vascular microlesions remains unknown.
Cells employ actin-rich protrusions to explore and interact
with the microenvironment and to navigate within tissue17–20.
When platelets bind to adhesive substrate, their cytoskeleton
undergoes rapid rearrangement and forms a broad circular
branched actin network, the lamellipodium, resulting in a pro-
totypic fried egg-like shape of spread platelets in vitro21. How-
ever, since the abrogation of lamellipodia formation does not
affect hemostatic or thrombotic platelet functions22,23 and visual
evidence of lamellipodia in vivo has so far not been provided, the
physiological role of platelet lamellipodia formation remains
enigmatic.
Adhesive cells employ Arp2/3-dependent lamellipodia to
establish integrin-mediated adhesions with the substrate and to
migrate along adhesive gradients24–26. This paradigm of integrin-
mediated directed cell migration along adhesive gradients is
referred to as haptotaxis27. While various studies confirmed the
crucial role of Arp2/3 in haptotaxis in vitro24,28, it still remains
unclear if branched actin networks are required for haptotaxis
in vivo29.
Here, we establish platelets as a reductionist, nucleus-free,
model system to study the role of branched actin networks in
integrin-mediated directional motility. We show that platelets
require Arp2/3-dependent branched actin networks to direc-
tionally migrate along adhesive gradients. Platelet haptotaxis
plays a critical role in vascular surveillance in vivo preventing
microbleeds and bacterial invasion during inflammation and
infection, while being dispensable for classical hemostasis. Our
findings therefore not only identify Arp2/3-dependent haptotaxis
as a crucial effector and intrinsic surveillance function of
immune-responsive platelets in vivo, but also functionally
establish the role of branched actin networks in integrin-mediated
directional motility within living organisms.
Results
Vascular fibrin(ogen) deposits instruct platelet shape and
motility in inflammation. To study morphodynamics of single
platelets in inflammation, we used multicolor 4D intravital
spinning-disk microscopy of the cremaster microvasculature
following exposure to lipopolysaccharide (LPS) (Supplementary
Fig. 1a and Supplementary Methods). Inflammation triggered the
accumulation of individual platelets in the microcirculation
(Fig. 1a). Platelets either transiently or firmly adhered to the
vessel wall and a fraction of adherent platelets subsequently
migrated autonomously, a motility pattern distinct from platelets
piggybacked by migrating leukocytes (Fig. 1b, Supplementary
Fig. 1b–d, and Supplementary Movie 1).
Interestingly, adherent and migrating platelets colocalized with
points of neutrophil extravasation (Supplementary Fig. 1e, f), the
predilection sites of inflammatory bleeding, which is suppressed
by platelets7.
To visualize morphological adaptations of single platelets
encountering the inflammatory microenvironment in situ, we
established an optimized fixation and super-resolution micro-
scopy protocol (see Supplementary Methods). We recently
identified the acute-phase protein fibrin(ogen) as a critical
adhesive ligand involved in platelet migration in vitro16. Indeed,
when we examined the inflamed cremaster microvasculature, we
detected a thin layer of fibrin(ogen), providing a two-dimensional
platform for adhesion of single platelets in vivo (Fig. 1c). In situ
morphological analysis of adherent platelets revealed the presence
of sheet-like lamellipodial protrusions resembling the phenotype
of platelet spreading and migration on a fibrin(ogen) layer
in vitro (Fig. 1d and Supplementary Fig. 1g). In contrast, we did
not detect lamellipodia formation in platelets recruited to the core
of fibrin(ogen)-rich thrombi that form after vessel injury (Fig. 1e).
In thrombi, platelets constituted a round shape with small spiky
protrusions reminiscent of filopodia (Fig. 1e and Supplementary
Fig. 1h)30,31. Unlike the two-dimensional (2D) fibrin(ogen)
patches deposited at the inflamed vessel wall, fibrin(ogen) in
the core of thrombotic lesions formed a three-dimensional (3D)
meshwork fully imbedding platelets (Fig. 1f, Supplementary
Fig. 1i, and Supplementary Movie 1). Contractile platelets exerted
isotropic pulling forces on formed thrombi, collectively leading to
thrombus retraction (Supplementary Fig. 1j)32. This collective
process was distinct from the exploratory behavior of platelets
migrating individually in the inflamed vasculature (Fig. 1g,
Supplementary Fig. 1k–m, and Supplementary Movie 1) or at the
periphery of vascular injuries16. Together, we identified distinct
patterns of fibrin(ogen) deposition during inflammation com-
pared to thrombosis, which triggered a characteristic morphology
and motility of individual platelets (Fig. 1g, h).
Platelets adapt to the mechanical composition of fibrin(ogen)
deposits. Based on these observations, we hypothesized that
platelets scan for fibrin(ogen) deposits in vivo and in turn adapt
their effector functions according to the physical presentation
of the ligand at the vascular lesion. To verify this, we coated
coverslips with fluorescently labeled fibrinogen in the absence or
presence of thrombin to generate thin fibrin(ogen) matrices with
or without 3D complexity (Fig. 2a, Supplementary Fig. 2a, and
Supplementary Methods).
Cross-linked fibrillar fibrin networks fostered a non-polarized,
round morphology and platelets remained stationary, while
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monomeric fibrin and fibrinogen surfaces triggered platelet
polarization and migration (Fig. 2b and Supplementary
Fig. 2b–e).
Time-lapse microscopy revealed that platelets recruited to non-
cross-linked fibrin(ogen) monolayers removed ligands from the
substrate, while the associated lamellipodial edges collapsed.
Platelets then polarized towards adjacent areas still coated with
fibrin(ogen), where lamellipodia remained stably attached to the
substrate (Supplementary Fig. 2f). This mechano-probing translated
into a polarized subcellular organization of the actomyosin
cytoskeleton and reinforced a half-moon-like platelet shape, leading
to migration resembling the morphodynamics of platelets recruited
to inflamed blood vessels (Fig. 2c, d). In contrast, platelets entangled
in cross-linked fibrin matrices radially aligned the fibrin meshwork,
thereby triggering isotropic contraction of the matrix (Supplemen-
tary Fig. 2d–g and Supplementary Movie 2)33,34. This behavior is
consistent with clot retraction observed during thrombosis in vivo
(Supplementary Fig. 1k). Importantly, cleavage of 3D fibrillar fibrin
mesh works by the serine–protease plasmin rescued polarization
and migration, highlighting the ability of platelets to instanta-
neously adapt their motility program to the physical composition of
the microenvironment (Fig. 2e, f and Supplementary Movie 2). To
confirm that mechanical rather than biochemical properties of
adhesive matrices are sufficient to instruct distinct platelet motility
programs, we coated coverslips with integrin ligands of tunable
mechanical stability (see Supplementary Methods and Fig. 2g).
When pulling forces of spreading platelets were overcoming the
ligand’s rupture threshold platelets polarized and migrated,
consistent with platelets migrating on fibrin(ogen) monolayers
(Fig. 2g and Supplementary Movie 2). Hence, platelets constantly
probe the mechanical properties of their microenvironment; when
contractile pulling forces overcome matrix stability, platelets remove
the weakened ligands, polarize, and migrate towards regions of
higher matrix densities. These observations raise the fundamental
question of how platelets sense fibrin(ogen) density.
Arp2/3-dependent haptotaxis guides platelets along fibrinogen
gradients. Platelet migration on fibrin(ogen) is preceded by the
formation of radially extending, spike-like filopodia, which are
followed by flat sheet-like lamellipodia (Fig. 3a, b and Supple-
mentary Movie 3). The dominant lamellipodium determines the
leading edge of the now polarized platelet and is a strong pre-
dictor of the direction of migration (Fig. 3c). We therefore
hypothesized a functional role of platelet lamellipodia in reading
and interpreting local fibrin(ogen) densities, as previously
reported for other cell types24,25. To test this hypothesis, we
generated coverslips coated with steep gradients of high to low
fibrinogen concentrations (Fig. 3d, see Methods section) and
analyzed decision-making of platelets in contact with both
regions. Platelets encountering the fibrinogen density interface
persistently migrated from regions of low into regions of high
fibrinogen densities, while changing direction upon sensing lower
substrate densities (Fig. 3d). As a consequence, virtually all pla-
telets repositioned to areas of higher substrate density (Fig. 3e).
Lamellipodia formation requires the polymerization of
branched actin networks initiated by the actin-nucleating Arp2/
3 complex22,24,25. In line with this, migrating platelets exhibited
Arp2/3 enrichment at the leading edge (Fig. 3f). Following the
addition of CK666, a specific Arp2/3 inhibitor35, platelets were
unable to undergo half-moon-like polarization, while spike-like
filopodia remained attached to the substrate (Fig. 3g). These
morphological changes were paralleled by abrogation of actin
polymerization at the leading edge and arrest of migrating
platelets without affecting platelet contractility and fibrin
reorganization (Supplementary Fig. 3a, b and Supplementary
Movie 3 and 4). Loss of lamellipodia was accompanied by a severe
reduction of fibrin(ogen)—integrin engagements at the platelet
periphery (Supplementary Fig. 3c) resulting in increased retro-
grade actin flow36 (Supplementary Fig. 3a and Supplementary
Movie 3). This indicates a role for lamellipodia in scanning for
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Fig. 1 Platelets recruited to inflamed blood vessels are migratory and form lamellipodia. a, b Platelet recruitment and migration in inflamed microvessels.
a Representative micrograph and b platelet migratory behavior, exemplary observed patterns, tracks (white) and cell velocities (n= 39 cells in five mice).
White arrows: platelets. c, f Platelet phenotype and microenvironment in LPS-induced inflammation and ferric chloride-induced thrombosis in the
cremaster microvasculature. c Fibrin(ogen) deposition and d associated platelet phenotype in inflammatory settings. Asterisks: lamellipodia. e Platelet
phenotype and f fibrin(ogen) deposition in thrombosis. White arrows: filopodia. c, f Right lower insets: rendered 3D reconstructions. g Directionality of
in vivo migrating (n= 39, see b compared to retracting cells (mesenteric thrombus formation, n= 59 cells in three mice), Mann–Whitney. h Analysis of
in vivo platelet shape in the cremaster microvasculature, n= 26 (thrombosis), n= 33 (inflammation) in three mice, Mann–Whitney. Scale bars=5 µm. All
statistical tests are two-sided. Source data are provided as a Source Data file.
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addition, CK666-treated platelets adhering at the interface of high
and low fibrinogen densities did not polarize nor migrate into
regions of high fibrinogen, but rather symmetrically extended
their filopodia into both regions (Fig. 3h, i). Hence, spreading
platelets use their lamellipodia to locally sense substrate
adhesiveness, eventually triggering polarization and migration
in direction to the higher adhesive area, a process referred to as
haptotaxis37 (Supplementary Fig. 3d).
Haptotactic platelets safeguard inflamed blood vessels. To study
the (patho-)physiological relevance of platelet haptotaxis in vivo,
we genetically deleted the Arp2/3 complex in platelets by gen-
erating PF4-Cre−/+; Arpc2fl/fl mice (referred to as Arpc2−/−).
Similar to CK666 treatment of human platelets, which preserved
normal hemostatic platelet functions, including adhesion (Sup-
plementary Fig. 3e) and clot retraction (Supplementary Fig. 3f, g),
Arpc2-deficient mouse platelets showed unaltered aggregation
(Supplementary Fig. 3h), only minor changes in the activation
(Supplementary Fig. 3i) and normal retraction, whereas platelet
migration and spreading was abrogated (Supplementary Fig. 3j and
Supplementary Movie 4). In line with the literature22, Arpc2−/−
mice presented normal tail bleeding times and formed
stable thrombi in a model of acute arterial thrombosis similar to
Arpc2+/+ controls with platelet counts adjusted to the level of
Arpc2−/− mice (Supplementary Fig. 4a–g, Supplementary
Movie 5, and Supplementary Methods).
When we examined the inflamed cremaster microvasculature,
wild-type (WT) platelets adhered to the endothelium and


































































































































   
   
































































Fig. 2 Mechanical properties of fibrin(ogen) are sufficient to instruct platelet shape and motility. a–d In vitro reconstitution of in vivo
microenvironments. a Substrate clearance and morphology of platelets on monomeric and cross-linked substrate. b Representative micrograph of
migrating and retracting cell on fibrinogen and cross-linked fibrin substrate and c mean shape outlines and comparison of the aspect ratio of cells on
fibrinogen leading to migration (n= 43 cells) and cells on cross-linked fibrin leading to retraction (n= 47 cells, Mann–Whitney). d p-MLC and F-actin
distribution in migrating and retracting human platelets. (Left) Exemplary cells and (right) FMI profiles along short axes in n= 50 (migrating) and n= 47
(retracting) cells from three experiments. e, f Plasmin treatment of cross-linked substrate after human platelet addition. e (Left) Experimental setup and
cleavage of fibers after plasmin treatment indicated by loss of fluorescence. (Center) Representative micrographs. (Right) Color-coded (time)
representative cell outlines. f Migrating cell percentage after plasmin/control treatment (n= 5 experiments, Mann–Whitney), and aspect ratio prior and
after treatment (n= 46 cells from four experiments, Wilcoxon’s signed-rank test). g Integrin ligands of tunable mechanical stability. Left: stable: RGD (Arg-
Gly-Asp)-peptides are covalently bound (stable) to a PLL (poly-L-lysine)-PEG (polyethylene glycol) backbone immobilized on a glass coverslip, fragile:
RGD-biotin is bound to a PLL-PEG-biotin backbone via a neutravidin-FITC (NA) bridge, middle: exemplary micrograph showing that platelet pulling forces
rupture NA–biotin bonds as indicated by the loss of fluorescence (FITC) and right: percentage of spreading and migrating platelets, n= 3 independent
experiments, t test. Scale bars= 5 µm. Error bars= s.e.m. All statistical tests are two-sided. Source data are provided as a Source Data file.
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of spreading and haptotaxis in the context of inflammation. In
striking contrast, Arpc2−/− platelets failed to form lamellipodia,
but rather developed prominent filopodia, leading to spiky cell
contours in vivo (Fig. 4a, b), consistent with our in vitro adhesion
assays (Supplementary Fig. 3j). Importantly, these morphological
alterations were accompanied by a significant reduction in
platelet migration, resulting in an increased fraction of non-
motile adherent cells, while rolling and leukocyte interaction/
motility remained unaffected (Fig. 4c and Supplementary
Movie 5).
Platelets prevent inflammatory bleeding from vascular lesions
caused by extravasating leukocytes7,8 (Supplementary Fig. 5a–e).
To achieve this, single platelet form sealing plugs precisely
positioned to cover endothelial microbreaches3,13. We therefore
hypothesized that directional spreading and migration towards
higher fibrin(ogen) densities may play a role in this process.
Indeed, fibrin(ogen) was enriched at endothelial cell junctions
(Fig. 4d), the major exit routes of transmigrating leukocytes38. In
Arpc2+/+ mice, we found a large fraction of adherent platelets
positioned in close contact with endothelial cell junctions (Fig. 4e).
In addition, platelets colocalized with areas of low pericyte
coverage (Fig. 4f) that constitute weak spots of the vessel wall
often penetrated by transmigrating leukocytes39.
Arpc2-deficient platelets were less efficiently recruited to spots
of leukocyte transmigration (Fig. 5e, f), suggesting a role of fibrin
(ogen) haptotaxis in preserving vascular integrity. Consistent with
previous reports, we did not observe macroscopic bleeds22,40;
however, Arpc2−/− mice showed increased inflammatory
microbleeds (Fig. 4g), despite comparable platelet numbers and
leukocyte recruitment patterns (Supplementary Fig. 5f–h). Like-
wise, interference with platelet-fibrin(ogen) engagement by
treating mice with integrin αIIb inhibitor tirofiban resulted in
comparable microbleeds (Supplementary Fig. 5i), while macro-
scopic bleeds were absent, as previously reported for the skin40,41.
We also observed increased microbleeds in Arpc2−/− in sterile
inflammation elicited by CCL-2 and causing extensive
Arp2/3 F-actin Merge
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Fig. 3 Arp2/3-dependent lamellipodia formation regulates platelet haptotaxis. a–c Early shape changes of human platelets on fibrinogen surfaces.
a Micrograph of spreading cell. Arrows: filopodia; asterisk: lamellipodium. b Evolution of lamellipodia/filopodia over time, and c direction of filopodia and
lamellipodia in relation to the subsequent direction of migration. b, c n= 32 cells from three experiments. Lines: mean; error bands: s.d. d, e Platelet
decision-making upon encountering substrate gradients. d (left) Exemplary line profile of fibrinogen gradients encountered by cells and (right)
representative micrographs of the substrate (green: fibrinogen-AF488) and platelet tracks (white), 30min after cell seeding. Scale bar= 5 µm. e Tracks of
cells (n= 256 cells) in contact with interface, and (right) platelet positioning before (0 min) and after migration of cells getting in contact with the interface
(45min), n= 4 experiments, paired t test. Scale bar= 10 µm. f Arp2/3 and F-actin distribution in migrating and retracting cells, and FMI profiles along
short axes in n= 50 (migrating) and n= 53 (retracting) cells pooled from three experiments. Scale bar= 5 µm. g Effect of Arp2/3 inhibition with CK666
compared to control CK689 on the number of filopodia per cell (Mann–Whitney), solidity (t test), lamellipodia formation, and F-actin distribution (compare
Fig. 1d). n= 41 cells from three experiments. Scale bar= 5 µm. h, i Decision-making upon encountering substrate gradients, control (CK689) and Arp2/3
inhibited (CK666) platelets (h) representative micrograph. Scale bar= 5 µm and i direction of lamellipodia and filopodia in relation to the fibrinogen
gradient, n= 168 filopodia and n= 51 lamellipodia, χ2 test. Error bars= s.e.m. Scale bars= 5 µm. All statistical tests are two-sided. Source data are
provided as a Source Data file.
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extravasation of neutrophils in the cremaster muscle, highlighting
a general role of platelet migration in the prevention of
microbleed independent of stimulus (Supplementary Fig. 5j).
Similar to the inflamed muscle tissue, we also observed
lamellipodia-forming platelets in contact with fibrin(ogen)
deposits in areas of vascular damage in a clinically relevant
model of LPS-induced acute respiratory distress syndrome
(ARDS) (Fig. 5a, b and Supplementary Methods). Arp2/3-
dependent positioning of platelets played a crucial role in
preventing inflammatory bleeding in the inflamed lung (Fig. 5c–f
and Supplementary Methods). While control mice showed only
mild intra-alveolar bleedings, Arpc2−/− mice developed severe
pulmonary hemorrhage (Fig. 5c–f and Supplementary Fig. 6a–k).
Consequently, Arpc2−/− mice suffered from impaired oxygen
saturation and higher mortality (Fig. 5g, h and Supplementary
Fig. 6l). Finally, and in contrast to transient pharmacological
inhibition41,42, genetic deletion of integrin αIIb, the major
fibrinogen receptor, phenocopied the bleeding tendency of
Arpc2−/− mice in the lung (Supplementary Fig. 6m), as also
reported for the inflamed brain microvasculature43. This further
indicates a crucial role of fibrin(ogen)-dependent platelet
spreading and migration in safeguarding the inflamed micro-
circulation. Taken together, Arp2/3-dependent spreading and
haptotaxis constitute crucial platelet functions required for
safeguarding the inflamed microvasculature in the muscle and
lung and preventing inflammatory microbleeds.
WASp and WAVE play a redundant role in platelet haptotaxis.
The Arp2/3 complex of platelets is activated by nucleation-
promoting factors (NPFs) of the Wiskott–Aldrich syndrome
protein (WASp) and WASp-family verprolin-homologous pro-
tein (WAVE) families17,26. To test the contribution of these NPFs
in platelet migration and haptotaxis, we analyzed platelets defi-
cient in WASp or Cyfip1, the Rac1-binding subunit of the WAVE
complex required for its activation in platelets31. WASp−/−
platelets formed lamellipodia similar to control platelets and
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Fig. 4 Platelet spreading and haptotactic migration preserve vascular integrity in inflammation. a, b Analysis of Arpc2+/+ and Arpc2−/− platelet
morphology in the inflamed microvasculature. a Cremaster whole mount of adherent platelets. Asterisk: lamellipodium; arrows: filopodia. b Filopodia per cell
and solidity, Arpc2+/+: n= 28 cells, Arpc2−/−: n= 30 cells in three mice per group, t tests. Scale bar= 5 µm. c Motility patterns of transfused Arpc2+/+
and Arpc2−/− platelets. Quantification of patterns (n= 21 vessels from three mice), Mann–Whitney. d Distribution and MFI profile of vessel-deposited
fibrinogen in relation to VE-Cadherin+ endothelial junctions. Scale bar= 5 µm. e Localization of Arpc2+/+ and Arpc2−/− platelets in relation to VE-
Cadherin+ endothelial junctions. (Left) Exemplary whole mounts, arrows indicate platelets adherent to junctions, asterisks highlight platelets distant from
junctions and (right) platelet distance from junctions, violin plot, Arpc2+/+: n= 135, Arpc2−/−: n= 144 cells from three mice per group, t test. Scale bar=
10 µm. f Platelet recruitment to α-SMA low regions in Arpc2+/+ and Arpc2−/− mice. (Left) Whole mount and (right) percentage of α-SMA low areas
positive for platelets, Arpc2+/+: n= 16, Arpc2−/−: n= 16 vessels from three mice per group, t test. Scale bar= 5 µm. White arrows: platelets. g Bleeding
assessment in the inflamed cremaster microvasculature of Arpc2+/+ and Arpc2−/− mice, representative whole mounts stained for erythrocytes (TER119)
and vasculature (CD31) and quantification of extravascular TER119 signal, Arpc2+/+: n= 8, Arpc2−/−: n= 5 mice per group, t test. Scale bar= 50 µm. Error
bars= s.e.m. All statistical tests are two-sided. Source data are provided as a Source Data file.
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a redundant role of WASp in lamellipodia formation and platelet
migration (Fig. 6a). Previous reports have shown that WAVE
rather than WASp is required for lamellipodia formation in
platelets31,44. Indeed, spreading area of platelets isolated from
conditional Pf4cre+/− Cyfip1fl/fl (Cyfip1−/−) mice was largely
reduced compared to controls (Fig. 6b) and adherent platelets
formed prominent filopodia (Fig. 6b), confirming previous
observations31. Time-lapse video microscopy, however, revealed
premature lamellipodia-like extensions that protrude and retract
between adjacent filopodia, but do not extend to filopodial tips
(Supplementary Movie 6); and mean projected platelet area was
significantly larger compared to Arpc2−/− platelets (Fig. 6c–e).
Cyfip1−/− platelets showed a slight, but not significant reduction
of migration and unimpaired removal of fibrinogen, indicating
that premature lamellipodia-like extensions were sufficient to
promote platelet migration (Fig. 6f, g). Incubation of Cyfip1−/−
platelets with the Arp2/3 inhibitor CK666 abolished migration,
indicating sufficient residual Arp2/3 activation at the leading edge
of migrating Cyfip1−/− platelets (Fig. 6h). Hence, Cyfip1−/−
platelets were able to haptotax and preferentially migrated to
higher fibrinogen densities (Fig. 6i). During ARDS, Cyfip1−/−
platelets prevented inflammatory bleedings of the lung (Fig. 6j),
despite the reduction of platelet counts to the level of PF4-Cre;
Arpc2fl/fl mice (Fig. 6k), indicating functional haptotaxis in vivo.
Consequently, and similar to previous reports of other cell
types45, our data suggest a partial redundancy of NPFs in the
activation of the Arp2/3 complex, which is sufficient to promote
migration when one or the other is deleted.
Vascular surveillance by lamellipodia-forming platelets pre-
vents bacteria dissemination within the host. We recently
identified platelet migration as a platelet function facilitating
platelet-pathogen interactions16. To gain access to the blood-
stream pathogens are known to exploit vascular breaches46. We,
therefore, hypothesized that haptotactic positioning of platelets at
vascular microlesions may serve as a physiological line of defense
capturing invading pathogens at primary sites of infection such as
the lung5,47,48.
Methicillin-resistant staphylococcus aureus (MRSA) is a major
cause of hospital-acquired pneumonia49,50 and platelets effi-
ciently sense, bind and interact with MRSA51. Consequently,
platelets were recruited to MRSA-containing biofilms (Fig. 7a–c).
Once activated, platelets spread and migrated, thereby collecting
and bundling MRSA on their surface, which led to the partial
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Fig. 5 Vascular surveillance by platelets prevents pulmonary bleeding. a, b LPS-induced (sub-)acute lung injury model. a Representative micrograph of
fibrinogen deposition (asterisks) and platelet morphology in the inflamed (LPS) and control lungs (NaCl) of WT animals. Asterisk: lamellipodium. Scale bar
= 5 µm. b Exemplary micrograph and quantification of fibrin(ogen) deposition at sites of vascular damage (arrows) compared to control mice indicated by
single extravasated erythrocytes and intact vasculature, n= 3 WT mice, paired t test. Scale bar= 5 µm. c, f LPS-induced lung injury in busulfan-treated
Arpc2+/+ and Arpc2−/− mice. c Appearance, d hemoglobin content in bronchoalveolar lavage (BAL), and e lung histology 8 h after LPS challenge. Scale
bar= 10mm. f Lung HE stain. Scale bar= 30 µm. d Mann–Whitney. g, h Hyperacute lung injury model. g SpO2 90min after high-dose tracheal LPS
application. Center: mean; whiskers: min–max; box: 25–75th percentiles. h Kaplan–Meier survival curve, n= 8 mice per group. g t Test and h log rank. Error
bars= s.e.m. All statistical tests are two-sided. Source data are provided as a Source data file.
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killing of bundled bacteria (Fig. 7a–c and Supplementary Fig. 7a–d
and Supplementary Movie 7)51. Inhibition of Arp2/3 reduced
collection and bundling of MRSA and attenuated platelet-
mediated killing of biofilm-associated pathogens (Fig. 7b and
Supplementary Fig. 7e).
Next, we inoculated mice withMRSA to assess platelet–bacteria
interactions in Gram-positive pneumonia (Fig. 7c and Suppl-
ementary Methods). After 48 h of infection, lungs were over-
grown with MRSA, largely accumulating in neutrophil-rich
abscesses, with a fraction of bacteria disseminated in the lung
vasculature (Supplementary Fig. 6f–g). We detected non-
aggregated platelets mainly outside abscesses, where they formed
lamellipodia and bundled bacteria that had escaped to non-
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Fig. 6 WASp and WAVE play a redundant role in platelet haptotaxis. a Morphology and migration of WASp−/− platelets compared to controls, n= 3
WASp+/+ and n= 4 WASp−/− mice, t test. Scale bar= 5 µm. b Number of filopodia per cell (Mann–Whitney), solidity (t test), and representative F-
actin-stained platelet of Cyfip1−/− (n= 32 cells) and Cyfip1+/+ (n= 30 cells) mice, three mice per group. c, d Representative cell body/filopodia outline
and c total cell area of Arpc2−/− (n= 31 cells) and Cyfip1−/− mice (n= 31 cells), and d size of cell body, three mice per group, t test. e p-MLC and F-actin
distribution of Arpc2−/− (n= 39 cells) and Cyfip1−/−mice (n= 39 cells), three mice per group. Insets: F-actin distribution between filopodia. Scale bar=
5 µm. f–g Migration of WT, Cyfip1−/−, and Arpc2−/− platelets, f representative micrographs, g percentage of cells migrating and area cleared per cell,
ANOVA and Tukey’s post hoc test, n= 3 mice per group. Scale bar= 5 µm. h Effect of additional Arp2/3 inhibition on Cyfip1−/− platelets. Representative
micrographs, and analysis of percentage of cells migrating and area cleared per cell of CK689- and CK666-treated Cyfip1−/− platelets, n= 3 mice per
group, paired t test. i Decision-making upon encountering substrate gradients, (left) examples of Cyfip1−/− platelets in contact with interface, and (right)
platelet positioning before (0min) and after migration (45min), n= 18 cells from three mice. j LPS-induced lung injury in Cyfip1+/+ and Cyfip1−/− mice,
quantification of hemoglobin content, erythrocytes, and leukocytes in bronchoalveolar lavage (BAL), n= 3 mice, t test. k LPS-induced lung injury in
busulfan-treated, partially platelet-depleted Cyfip1+/+ and Cyfip1−/− mice. Quantification of hemoglobin content, erythrocytes, and leukocytes in











































































































































































































































































Fig. 7 Migrating platelets protect from bacterial dissemination in MRSA pneumonia. a Platelet recruitment and clearance in sterile and MRSA biofilms
in vitro, n= 5 experiments, Mann–Whitney. Scale bar= 10 µm. b In vitro effect of Arp2/3 inhibition with CK666 compared to control CK689 in platelet-
mediated MRSA biofilm clearance. (Left) Percentage of MRSA associated with platelets, n= 7 experiments, t test, and (right) 3D reconstruction of
platelets interacting with MRSA. Scale bar= 5 µm. c Scanning electron microscopy of platelet surface-bound MRSA. Inset: bundled bacteria. Scale bar= 1
µm. d–i MRSA lung infection model of Arpc2+/+ and −/− mice, (d) (left) mice were intranasally inoculated, and (right) exemplary micrograph of
platelet–MRSA interaction in the lung of Arpc2+/+ mice. Asterisks: lamellipodium; arrows: bundled bacteria. e Micrographs of platelet–MRSA localization
and f percentage of MRSA associated with platelets in non-abscessing infected lung tissue (Arpc2+/+: n= 7, Arpc2−/−: n= 9 mice per group).
g Percentage of mice with bacteremia was assessed 24 h (n= 16) and 48 h p.i. (Arpc2+/+: n= 11, Arpc2−/−: n= 12 mice per group). h MRSA CFUs
recovered from blood at 48 h p.i. (i), percentage of mice with MRSA in the kidney and spleen (Arpc2+/+: n= 15, Arpc2−/−: n= 16 mice).
d, h Mann–Whitney and g, i χ2. Scale bars= 5 µm. Error bars= s.e.m. All statistical tests are two-sided. Source data are provided as a Source data file.
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Platelet–bacteria interactions in the vasculature were significantly
reduced in Arpc2−/− mice, indicating an important role for
platelet spreading and migration in this process (Fig. 7d, e).
Importantly, the number of recruited platelets and neutrophils, as
well as neutrophil activation and abscess formation, was not
affected by the loss of Arpc2 in platelets (Supplementary
Fig. 7h–k). To determine whether impaired bacterial capture by
platelets had an impact on bacterial dissemination within the
organism, we quantified MRSA in the blood and at distant organ
sites 24–48 h following a lung infection. While bacterial loads
within the lung remained unaffected, Arpc2−/− mice were prone
to developing bacteremia, resulting in an increased fraction of
mice with disseminatedMRSA in the kidney and spleen (Fig. 7f–h
and Supplementary Fig. 7l). Consequently, platelets use their
ability to spread and directionally migrate to capture invasive
bacteria at the primary foci of infection, thereby preventing
dissemination within the host.
Discussion
Since the morphological characterization of platelet spreading in
the 1970s21,52, platelet lamellipodia formation has evolved a
reductionist model to study the actin cytoskeleton and adhesion
formation53–55. Yet, its physiological function remained largely
enigmatic22,23. Our study now provides evidence of a functional
role of branched actin networks of platelet in vivo. Spreading
platelets use lamellipodial protrusions to scan for adhesive cues
within the inflammatory microenvironment, allowing individual
platelets to haptotax and optimize their position at the
vascular wall.
Soluble fibrinogen is a highly abundant plasma protein (2–4
mg/ml) that becomes immobilized at thrombotic lesions, but also
at sites of inflammation56. We show here that during inflam-
mation vascular fibrinogen deposits flag up and tag weak
points in the inflamed endothelium. Surface-anchored fibrin-
(ogen) is recognized and bound by platelet integrin αIIbβ357.
Mechanosensing platelets in turn use integrins to transmit
forces from the actomyosin cytoskeleton to the substrate58
and subsequently adapt their effector functions to the
mechanical properties of the microenvironment33,34. When the
cytoskeleton–integrin–substrate linkage overcomes a critical
tension threshold integrins become activated (outside–in signal-
ing) and platelets firmly adhere59,60. In contrast, a fragile sub-
strate rupturing below this critical tension threshold impedes
integrin activation59. Thus, mechanical substrate properties play a
critical role in initiating platelet activation and adhesion. Here, we
now report a second mechanical checkpoint allowing activated,
adhesive platelets to switch from isotropic contraction to aniso-
tropic migration. When pulling forces generated by adhesive
platelets overcome substrate stability, platelets start to pile-up the
weakened ligands and scan the microenvironment to establish
new adhesive bonds. Platelets then preferentially migrate towards
areas of higher integrin-ligand density, a process referred to as
haptotaxis37.
Platelet haptotaxis is not restricted to preformed density gra-
dients of integrin ligands. Adhesive platelets generate high trac-
tion forces that instantaneously deplete weak integrin ligands
from the underlying substrate and form steep, self-generated
haptotactic gradients. This ability allows platelets to locally and
dynamically respond to changes of substrate mechanical prop-
erties and to migrate to areas of high ligand stability, as observed
during fibrinolysis of stable fibrin networks. The concept of self-
generated gradients has been described for chemotactic cells
migrating in homogeneous chemokine solutions where binding of
the chemotactic ligand to dummy receptors sequesters and
removes the ligand and serves as a sink to generate local
chemokine gradients61. Together, our data highlight single pla-
telets as autonomous mechanosensors that, in addition to
mechanical remodeling of the substrate33, use integrins to probe
their adhesive microenvironment and to optimize their own
positioning.
In line with previous studies in other adhesive cell types, we
show that two-dimensional, sheet-like lamellipodia, but not one-
dimensional, needle-like filopodia, are the mechanosensitive
platelet protrusions required for the spatial integration of signals
from cell–matrix adhesion sites19,24,28,29. Consequently, abroga-
tion of branched actin networks and lamellipodia formation
blocks platelet migration and haptotaxis. Importantly, Arp2/3-
dependent actin nucleation was required for directional platelet
migration in vivo, establishing a role of branched actin networks
in directional integrin-dependent migration in living organisms.
Arp2/3 in platelets is activated by NPFs of the WAVE and WASp
families, as well as cortactin and HS131,44,62. Patients with loss-of-
function mutations of WASp present with immunodeficiency and
bleeding complications, known as Wiskott–Aldrich syndrome63.
Consequently, it was tempting to speculate whether impaired
platelet migration and haptotaxis contribute to the clinical
symptoms of WAS patients. Our data show that single deletion of
neither WASp nor WAVE was sufficient to fully inhibit Arp2/3
activation at the leading edge and to block platelet migration and
haptotaxis, suggesting redundancy of NPFs in this process45.
Further studies will be required to shed light on the mechanisms
of Arp2/3 activation in migrating platelets and to investigate the
mechanistic framework underlying the partial redundancy
of NPFs.
Platelet haptotaxis is not required for acute thrombotic and
hemostatic clot formation. During thrombosis and hemostasis,
large numbers of platelets are simultaneously activated and
embedded within a stable three-dimensional fibrin network that
prevents platelet polarization and migration. In contrast, platelets
recruited in inflammation employ a different strategy: they scan
the mechanical properties of the substrate and follow two-
dimensional haptotactic fibrin(ogen) gradients to optimize their
position and to safeguard vascular microbreaches. Autonomous
navigation of single platelets at sites of inflammation and infec-
tion is required to efficiently prevent inflammatory bleedings and
bacterial invasion without the need of forming large platelet
thrombi, which would run the risk of causing detrimental vessel
occlusions64,65 (Supplementary Fig. 7m).
In conclusion, we identified Arp2/3-dependent lamellipodia
formation and haptotaxis as a distinct molecular signature of
immune-responsive platelets in vivo. Platelet haptotaxis endows
platelets with the ability to scan the vascular endothelium for
inflammatory microlesions. Plugging of microlesions by migrat-
ing platelets helps prevent inflammatory microbleeds and sup-
presses bacterial dissemination within the host. Hence, platelet
migration and lamellipodia formation serve two key functions in
fighting infections: they not only collect bacteria that already
gained access to the intravascular compartment16, they also serve
as gate-keepers of the inflamed vasculature preventing invasion of
extravascular bacteria. Pharmacological manipulation of lamelli-
podia formation may therefore provide a strategy to address
platelets’ immunological functions without affecting physiological
hemostasis. In addition, developing anti-platelet drugs that pre-
serve lamellipodia formation may help to avoid unwanted
immune-related side effects of anti-platelet therapy66.
Methods
Mouse strains. PF4-Cre67, LifeAct-eGFP68, Rosa26-Confetti69, WASp−/−70, and
C57BL/6 mice (labeled WT mice) were purchased from The Jackson Laboratory
and maintained and cross-bred at our animal facility. IL4R/GPIb-tg mice were a gift
of Dr. Ware71. αIIb mice were a gift of Dr. Frampton72. Arpc2fl/fl mice were
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provided by Rong Li and the Wellcome Trust Sanger Institute73,74. Cyfip1fl/fl mice
were recently described31. For a list of primers used for genotyping of all strains,
please refer to Supplementary Data 2. All strains were backcrossed to and main-
tained on C57BL/6 background. Both male and female mice were used in this
study. If not otherwise stated, animals of control and experimental group were sex-
matched and age-matched (6–12 weeks) and randomly assigned to experimental
groups, and PF4-Cre-negative control animals were used as controls. PF4cre+/−
Arpc2fl/fl mice exhibit mild thrombocytopenia22. To exclude differences in platelet
counts as a possible confounder, platelet counts were adapted in Arpc2+/+ control
animals via partial low-dose busulfan depletion for in vivo experiments comparing
Arpc2−/− with Arpc2+/+ mice (see Supplementary Fig. 3k), if not indicated
otherwise. For sepsis experiments, knockout (KO) and control animals were paired
according to age, sex, and weight. All mice live in standardized conditions where
temperature, humidity, and hours of light and darkness are maintained at a con-
stant level all year round. All animal experiments were performed in compliance
with all relevant ethical regulations for studies involving mice and were approved
by the local legislation on protection of animals (Regierung von Oberbayern,
Munich). For a detailed overview over-performed mouse experiments, please see
Supplementary Data 1.
Human blood donors. Human blood was drawn from male and female healthy
voluntary donors at the age of 25–40 years after informed consent was obtained
from all subjects. Both genders were equally represented in all our analyses.
Experiments involving human subjects have been approved by the ethical review
board (LMU Munich) and complied with relevant regulation for experiments
involving human samples.
Bacterial strains. MRSA strain USA300 was cultured similarly to published
protocols16. Briefly, bacteria were cultured overnight in brain heart infusion (BHI,
BactoTM Brain Heart Infusion (Porcine), BD) medium at 37 °C with 180 r.p.m.
shaking. The CFU (colony-forming units) per milliliter (ml) of the overnight
culture was determined for OD600= 2 with 6.7 × 108 CFU/ml and was directly
used for in vitro experiments. For infection experiments, the overnight culture was
diluted in BHI to OD600= 0.1 and further incubated at 37 °C to an OD of 2 (~4.5
h), corresponding to 6.7 × 108 CFUs/ml. Bacteria were centrifuged, and the final
infection dose was diluted in 30 µl of 0.9% sodium chloride (NaCl) solution
(Braun) and kept on ice until injection.
Antibody and reagents
Antibodies. For IVM (in vitro maturation), flow cytometry and histology/immu-
nofluorescence staining the following dyes were utilized: fluorescein isothiocyanate
(FITC), phycoerythrin, allophycocyanin (APC), eFluor660, and AlexaFluor 488,
594, and 647. Used antibody clones were anti-mouse Ly6G/C (clone RB6-8C5),
anti-mouse CD31 (MEC13.3), anti-mouse Ly-76(TER119), anti-mouse GpIb
(X488/X649, derivatized, polyclonal, Emfret), anti-mouse α-SMA (1A4), anti-
mouse VE-Cadherin (VECD-1), anti-mouse hIL4-R (MAB230, R&D), anti-mouse
p34-Arc/ArpC2 (Merck Millipore), anti-mouse Arp2 (polyclonal, ECM Bios-
ciences), anti-mouse Arp3 (monoclonal, FMS338, Sigma), anti-mouse GPVI
(HY101), anti-mouse CD62P(RMP-1), anti-mouse-activated CD41 (JonA), anti-
human CD41(HIP8) anti-human-activated CD41(PAC-1), anti-human CD62P
(AC1.2), anti-human CD42b(HIP1), anti-human Arp2/3 (13C9, Merck), anti-
human phospho-myosin light chain 2 (p-MLC, Thr18/Ser19, Cell Signaling), anti-
fibrinogen (sheep polyclonal, Bio-Rad), S. aureus antibody (polyclonal, Sigma).
Used secondary antibodies included: goat anti-rabbit, goat anti-sheep, and rat anti-
mouse (all Thermo Fisher). For platelet depletion, purified rat anti-mouse GP1bα
antibodies and control immunoglobins (R300, Emfret) were used; for neutrophil
depletion, anti-Ly6G (1A8) was used. Antibodies were purchased from BioLegend
or BD Biosciences, if not stated otherwise. Antibodies were used 1:100, and sec-
ondary antibodies were used 1:200, if not indicated otherwise. Appropriate species,
class, and subclass matched control antibodies were used.
Inhibitors. aIIbb3 inhibition: Abciximab (C7E3-Fab) from Janssen and Tirofiban
from Ibigen, myosin IIa inhibition: blebbistatin(−) (Cayman Chemical) (50 µM);
blebbistatin(+) (Cayman Chemical) was used as a negative control. To avoid
fluorescence-induced toxicity, para-nitroblebbistatin (50 µM, Optopharma) was
used in a subset of experiments. Arp2/3 complex inhibition: CK666 (200 µM) and
negative control: CK689 (both Merck Millipore). Actin polymerization inhibition:
cytochalasin D (2.5 µM) (Sigma). Other: carboxyfluorescein succinimidyl ester
(CFSE), Annexin V, busulfan, plasmin, thrombin, Fluo-4 AM, LPS O111:B4, CCL-
2 (Sigma) iron (III) chloride (FeCl3), casein, recombinant human albumin (HSA),
fibrinogen from human plasma, unconjugated and conjugated to AlexaFluor 488
and 594, Rhodamine 6G, adenosine diphosphate (ADP), NP40, polyethylene glycol
400 (PEG400), phalloidin-AlexaFluor 488, hexamethyldisilazane (HMDS), paraf-
ormaldehyde (PFA), GDA, and LIVE/DEAD BacLight Bacterial Viability Kit were
purchased from Sigma-Aldrich. Horm collagen was from Takeda, prostaglandin
I2 sodium salt from Abcam, and U46619 from Tocris.
Mouse anesthesia. If not stated otherwise, anesthesia was performed by isoflurane
induction, followed by intraperitoneal injection of medetomidine (0.5 mg/kg body
weight), midazolam (5 mg/kg body weight), and fentanyl (0.05 mg/kg body
weight). Toe pinching reflexes and breathing pattern were used to determine the
adequate depth of anesthesia. Core body temperature was maintained by heating
pads, and narcosis was maintained by repetitive injections of 50% of the induction
dose, if necessary.
Spinning disc IVM of cremaster microvasculature. To assess platelet motility
patterns under inflammatory conditions, we either injected fluorescent fibrinogen
(150 µg) and antibodies to label platelets (X649, 25 µl) and leukocytes (CD45-PE,
15 µl), or adoptively transferred cells, before intrascrotal LPS (50 µg O111:B4, in
400 µl NaCl 0.9%) application. After 4 h, the cremaster muscle was carefully pre-
pared for intravital microscopy75. An upright spinning-disk confocal microscope
(3i Examiner, Zeiss, ×20 objective, laser power 30%) was used for 4D image
acquisition (512 × 512 px, z-slices of 2.5 µm thickness, acquisition 17–23 s/frame).
Multiple areas of platelet recruitment were identified and imaged up to 1 h.
Busulfan depletion. To adjust platelet counts in PF4-Cre-negative Arpc2fl/fl
(Arpc2+/+) or WT animals to Arpc2−/− levels (~30–50% reduction of platelet
counts22,76) we used an established partial depletion model77. Briefly, busulfan (25
mg/ml in PEG400) was heated to 70 °C and diluted 1:10 in warm NaCl. Mice
received 20 µg/g weight intraperitoneally −14 and −11 days before the experiment.
This partial depletion method was performed for all in vivo experiments com-
paring Arpc2+/+ and Arpc2−/− mice.
Adoptive transfer
Imaging. For adoptive transfer experiments, intracardially drawn blood was diluted
1:1 in modified Tyrodes buffer (pH 6.5) and centrifuged (25 min, 70 × g). The
supernatant was incubated with either DyLight 488 or DyLight 649 anti-platelet
antibody (Emfret, 1:100). To determine platelet counts, a fraction was measured on
a hemocounter (Horiba). After 20 min, 2× excess Tyrodes buffer was added and the
labeled platelets pelleted (1200 × g, 10 min). The pellet was resuspended in Tyrodes
buffer to a final count of 108 platelets/100 µl (injection doses). KO (PF4cre-Arpc2)
platelets were injected in parallel with respective cre-negative control platelets, as
well as phycoerythrin-conjugated CD45 antibody (12 µl per mouse) to visualize
leukocytes. After tail vein injection, cremaster inflammation and imaging were
performed as described in “Spinning disc IVM of Cremaster Microvasculature.”
Antibody labeling color was switched between experiments and the researcher who
performed quantification of movement patterns was blinded for color assignment.
Depletion and substitution. To substitute recipient mice with transferred platelets,
IL-4R/GPIb-tg mice were used16,78. In detail, thrombocytopenia was induced in IL-
4R/GPIb-tg mice by i.v. injection of antibodies against hIL-4R (2.5 mg/g body
weight; 12 and 3 h before transfusion). WPs from Arpc2−/− and +/+ were iso-
lated as described above. Platelets from several donor mice were pooled, and 2 ×
108 platelets/mouse were injected.
Cremaster whole-mount and super-resolution microscopy. For whole-mount
assessment of the cremaster microvasculature, mice were sacrificed 6 h after
intrascrotal LPS challenge (50 µg, O111:B4) or CCL-2 challenge (0.3 µg), and after
incision of the right atrium, the animal was perfused with 10 ml of 0.1% PFA in
phosphate-buffered saline (PBS). To maintain platelet in vivo, morphological
phenotype (filopodia and lamellipodia) mice were perfused with 10 ml of 0.1% PFA
and 0.005% GDA in PBS for shape assessment experiments. For thrombosis
assessment, cremaster was surgically exposed and treated with FeCl3 solution
(Sigma, 10%) for 20 min. Then, mice were perfused with 10 ml of 0.1% PFA and
0.005% GDA in PBS. Cremaster muscles were excised and fixated in either 4% PFA
for 10 min or 2% PFA supplemented with 0.01% GDA-PFA for 20 min. Permea-
bilization was achieved by incubating the tissue for 2 h in 2% bovine serum
albumin (BSA) with 0.1% NP40 and Triton X-100. Antibody staining was per-
formed overnight with primary labeled antibodies. GDA-PFA fixation allowed for
assessment of bleeding (extravascular erythrocytes outside of CD31+ vessels), as it
preserved extravascular tissue integrity. For all other experiments, PFA fixation was
used. After embedding in Mounting Medium (Sigma), whole mounts were assessed
with a confocal microscope. For assessment of fibrin(ogen) deposition, AF594-
conjugated fibrinogen was injected 10 min before LPS challenge (120 µg). To dif-
ferentiate individual platelets and their morphology in thrombi, the multicolor
platelet reporter mouse PF4cre+/−Rosa26-Confetti was used. For depletion
experiments, WT mice received commercially available platelet depletion antibody
or control (R300, or C301, Emfret) i.v. (2 µg/g)79. After 24 h, neutrophils were
depleted by intraperitoneal injection of anti-Ly6G clone 1A8 or IgG isotype as
control (100 µg/mouse)80. After 12 h, mice were subjected to the cremaster
hemorrhage model as described. For analysis of the role of integrin αIIb in the
prevention of microbleeds, Tirofiban (0.5 μg/g body weight) or a similar amount of
NaCl as control was injected prior and 3 h after LPS-induced inflammation, and
bleeding was assessed at 6 h post infection (p.i.). Repeated injections were necessary
due to the short half-life of the drug. Whole mounts were imaged with an inverted
Zeiss LSM 880 in AiryScan Super Resolution (SR) Mode (10/0.3 obj. or ×20/0.8 obj.
for overviews, ×40/1.3 oil immers. obj. for single-cell analysis). For in vivo mor-
phology assessment, areas of high leukocyte recruitment were examined for
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platelets undergoing shape change. To assess platelet shape, 3D z-stacks were
recorded (0.5 µm stack interval) and thrombotic lesions were scanned in full to
exclude spread of platelets at the periphery of the clot. After a maximum
intensity projection (MIP) of these cells, cell outlines were traced manually, and
shape descriptors were calculated similarly to in vitro platelet morphology
assessments.
Confocal IVM of the mesentery. After induction of narcosis, animals received 15
µg of X488 antibody (Emfret) and 80 µg of fibrinogen-AlexaFluor 594 conjugate to
visualize platelets and fibrin(ogen), respectively, and confocal microscopy of the
mesentery was performed32. Briefly, the skin and peritoneum were opened along
the midline, and 200 µl of warm PBS was pipetted into the abdominal cavity. Next,
the proximal bowel was carefully exteriorized onto a glass coverslip and the
mesenteric vessels exposed. Wet tissue paper was used to stabilize the bowel and
prevent artifacts from bowel movements. A 1 × 1mm piece of filter paper was
saturated with 10% FeCl3 solution and carefully placed in direct contact with a
mesenteric vein for 3 min. Next, the ensuing thrombus formation and thrombus
contraction was imaged on an inverted Zeiss LSM 880 in AiryScan Fast Mode
(×20/0.8 obj., 990 ms/frame, laser power: 0.96%).
FeCl3-induced thrombus formation in the mouse carotid artery. Arterial
thrombosis was performed similar to published protocols81: mice were anesthe-
tized, and the left carotid artery was exposed. A DyLight 488-conjugated Gp1b
antibody (X488, Emfret, 50 µl) was injected via the tail vein to visualize platelets.
Next, a filter paper (mm3) was saturated with FeCl3 solution (Sigma, 10%) and was
placed abounding the vessel laterally. The paper was removed after 4 min and the
ensuing thrombus formation was imaged on a fluorescence microscope (Axio-
Scope; Carl Zeiss) with shots recorded every 5 min for a duration of 30 min. For
image acquisition and analysis, a computer (Dell) with CellR software (Olympus)
was used. The platelet signal was used to quantify thrombus area in relation to
vessel area over time. For histology, thrombi were retrieved after vessel occlusion
and snap-frozen. Kryo-histology slices (10 µm thickness) were labeled with fibri-
nogen and CD41 antibody, and imaged on an LSM 880 confocal microscope with
Airyscan module from Carl Zeiss (×40/1.3 oil immers. obj.).
Deep vein thrombosis model of the IVC. Thrombosis by ligation of the inferior
vena cava (IVC) was conducted by performing a median laparotomy, and placing a
space holder followed by a narrowing ligature82, see Supplementary Fig. 1i. At 24 h
after induction, the thrombus was retrieved and snap-frozen. Kryo-histology slices
(10 µm thickness) were labeled with fibrinogen, CD41 antibody, and DAPI (4′,6-
diamidino-2-phenylindole), and imaged on a Zeiss Axio Imager M2 epifluorescent
microscope with a ×10 and ×40/0.75 air objective and an AxioCam MRm camera
(Carl Zeiss Microscopy).
Tail bleeding assay. Mice were anesthetized as described above, 5 mm of the tail
was cut with a precision scissor (MST) and the tail was immediately placed in 37 °C
warm NaCl (0.9%) solution. Bleeding and re-bleeding times were recorded for
20 min.
Lung infection with S. aureus. For these experiments, we used bone marrow
chimeric mice reconstituted with PF4cre/Arpc2 Cre+/− (KO) or Cre−/− (Ctrl)
bone marrow. Anesthetized mice were intranasally injected with 3.2 × 107 CFU/g
mouse weight50 of S. aureus USA300. At 24 and 48 h p.i., 100 µl blood was drawn
from the facial vein under brief anesthesia (isoflurane) and plated on BHI plates
(Biomerieux) to assess bacteremia. At 48 h p.i., animals were sacrificed, and organs
were carefully explanted under sterile conditions to avoid external contamination.
CFU counts. To assess CFU counts, blood, left kidney, left lung, and anterior spleen
were weighted, and processed with a tissue homogenizer (4000 r.p.m., 30 s, Bead-
Bug Homogenizer, Biozym). Then, serial dilutions were plated on BHI plates
(Biomerieux) and colony counted after incubation for 20 h at 37 °C.
Histology. Organs were placed in 4% PFA for 1 h, 30% sucrose overnight, and then
cryo-embedded. Ten-µm-thick lung cryo-slices were labeled with Gp1b-DyLight
649, S. aureus antibody-AlexaFluor 555 (secondary), Gr-1-AlexaFluor 488/anti-
fibrinogen 488 (secondary), and anti-citrullinated H3 antibody (for quantification
of NETosis and NETosis-primed neutrophils). We identified areas of high bacteria
and neutrophil content classified as “abscesses.” Areas of disseminated bacteria
without neutrophil accumulation were classified as “infected tissue.”
Platelet–bacteria interaction was quantified in “infected tissue.” A Zeiss Axio
Imager M2 epifluorescent microscope with a ×40/0.75 air objective and an Axio-
Cam MRm camera (Carl Zeiss) or an LSM 880 confocal microscope with Airyscan
module (Carl Zeiss, ×20/0.8 air obj.) were used for image acquisition.
Chimera generation. Bone marrow chimeras were generated by irradiation of
recipient C57Bl6 mice. Six- to eight-week-old mice were irradiated twice within a
4-h interval (195 kV, 10 mA) and received isolated bone marrow from the,
respectively, indicated mouse strains83. Bone marrow from cre-negative/WT lit-
termates was used in the control group.
LPS-induced lung injury model. Two different models of acute lung injury were
performed. Subacute lung injury (bleeding assessment)41: mice were anesthetized
and received 20 µg of LPS (O111:B4) intranasally. After 24 h, animals were sacri-
ficed, and BAL was obtained by flushing the lung twice with 1 ml PBS containing 2
mM EDTA. Hemoglobin content was assessed after sonication by fluorescence
absorption (405 nm, Tecan Infinite F200), and flow cytometry was performed
utilizing Rainbow Beads for cell content per volume quantification. For histology,
lungs were directly harvested after 8 h, placed in 4% PFA for 1 h, and then in 30%
sucrose overnight and cryo-embedded. Ten-micrometer slices were then stained
with TER119-PE. Acute severe lung injury: to assess effects on survival, mice were
anesthetized, and the trachea was exposed surgically81. Fifty micrograms of LPS
(O111:B4) were injected directly into the lower trachea and bronchi. Anesthesia
was maintained, for 4 h. Blood oxygen saturation was measured repeatedly by
noninvasive pulse oximetry using MouseOx Plus (Starr Life Sciences, USA). The
experiments were carried out in deep anesthesia as described above and were
terminated (and counted as deceased), if mice showed clinical signs of respiratory
failure or oxygen saturation below 60%.
Bone marrow whole mount and flow cytometry. To assess the effect of busulfan
depletion on bone marrow function and ascertain time-dependent specificity, bone
marrow from control and busulfan-treated WT animals was harvested. For whole
mounts, bones were snap-frozen after PFA fixation (4%, 60 min) and sucrose
treatment (30%, overnight). Bones were then cut longitudinally with a cryotome to
expose marrow, and were stained with CD41-488, Gr-1-647, and TER119-PE
(1:100) and imaged with a Zeiss LSM 880 confocal microscope (×20/0.8 obj.) in
airyscan mode.
Blood counts. If not stated otherwise, blood counts were obtained in EDTA
anticoagulated blood with an ABX Micros ES60 (Horiba Diagnostics) cell counter.
Platelet isolation. Human blood was drawn from the cubital vein into a syringe
containing 1/7th volume of acid-citrate-dextrose (39 mM citric acid, 75 mM
sodium citrate, 135 mM dextrose; ACD), diluted 1:1 with modified Tyrode’s buffer
(137 mM NaCl, 2.8 mM KCl, 12 mM NaHCO3, 5.5 mM glucose, 10 mM HEPES,
pH= 6.5), and centrifuged with 70 × g for 35 min at room temperature (RT) with
the break switched off. The supernatant consists of platelet-rich plasma (PRP),
either directly used for experiments or used for the preparation of WPs by a 1:3
dilution in modified Tyrode’s buffer (pH= 6.5) with PGI2 (0.1 mg/ml) and a
second centrifugation step (1200 × g, 10 min, RT) and re-suspension of the cell
pellet in Tyrode’s buffer (pH= 7.2). Platelet-poor plasma (PPP) was obtained by
high-speed centrifugation of PRP (14,000 × g, 5 min). Mouse blood was drawn
intracardially from anesthetized mice and processed as described for human pla-
telets. Baboon blood was drawn from a central venous catheter and processed
similarly.
2D migration/retraction assay. For all in vitro migration/retraction experiments,
human platelets were used if not indicated otherwise. Coverslips (no. 1.5, D263T,
Nexterion) were acid washed (20% HNO3) for 1 h and rinsed in ddH2O for another
hour. Coverslips were then air-dried and silanized with HMDS by spin coating at
80 r.p.s. (revolutions per second) for 30 s. Plastic channels (sticky slides IV0.4, Ibidi)
were attached in all experiments, except Supplementary Fig. 2d; here, a ring was
glued to the coverslip to increase DIC imaging quality (open chamber assay).
Fibrin(ogen) surface generation. For fibrinogen surfaces, coverslips were coated
with 37.5 µg/ml AlexaFluor-conjugated fibrinogen and 0.2% HSA in modified
Tyrode’s buffer for 15 min at RT. (Monomeric) fibrin surfaces were generated by
the addition of 1 U/ml thrombin and 1 mM calcium. To create cross-linked fibrin
substrates, 1:4 PPP or fibrinogen/HSA at concentrations resembling PPP con-
centrations (final concentration 625 µg/ml and 10 mg/ml, respectively) was added
prior to thrombin addition. Visualization was ensured by spiking in labeled
fibrinogen at 37.5 µg/ml.
Fibrinogen edge. Non-homogenous fibrinogen for haptotaxis experiments was
coated by performing 1 µl dot coating for 15 min before attaching plastic channels.
Then, washing and plating steps were performed as described above.
Integrin ligands of tunable mechanical stability. Acid-washed glass coverslips
(HCO3 (20%); 1 h at RT) were plasma cleaned (Zepto; Diener Electronic GmbH).
Plastic channels ((sticky slides IV0.4, Ibidi) were attached to the coverslips and
subsequently coated (30 min at RT) with PLL(20)-g[3.5]-PEG(2)/PEG(3.4)-RGD
(1 mg/ml in PBS, SuSoS) to generate stabile, covalently bound RGD-containing
substrates. Fragile RGD substrates were generated by introducing a biotin-
neutravidin–biotin bridge linking RGD to the PLL–PEG (poly-L-lysine-PEG)
backbone. The biotin–avidin bond ruptures at forces >160pN84, thus allowing
platelets to mechanically remove an RGD-containing ligand when integrin pulling
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forces overcome 160 pN. Plasma-cleaned glass coverslips were coated with PLL
(20)-g[3.5]–PEG(2)/PEG(3.4)–biotin (50%) (0.1 mg/ml diluted in 1 mg/ml PLL
(20)-g[3.5]–PEG(2)/PEG(3.4) in PBS; 30 min at RT; SuSoS). PLL-g-PEG-biotin-
functionalized coverslips were subsequently incubated with NeutrAvidin-FITC
(200 µg/ml in PBS, Invitrogen) for 30 min at RT, followed by the incubation with
cyclo RGDfk-biotin [Arg-Gly-Asp-D-Phe-Lys(Biotin-PEG-PEG)] (0.1 μM in
ddH2O, Peptides International) for 30 min at RT. Slides were washed with PBS and
incubated with washed platelets in the presence of platelet activators (4 µM ADP, 2
µM U46619) and 1 mM Ca2+/Mg2+. Time-lapse movies were recorded as
described above.
Cell activation and plating. Washed platelets were added to modified Tyrode’s
buffer containing 0.1% HSA (migration buffer) to reach a final concentration of
10 × 106 platelets/ml, activated by the addition of 4 µM ADP, 2 µM U46619, and
200 µM calcium, and pipetted unto the coverslips. After 15 min at 37 °C, non-
adherent cells were removed by replacing buffer with cell-free migration buffer, if
not indicated otherwise. After 45 min at 37 °C, cells were fixated with 1% PFA.
Pharmacological inhibition studies. For inhibition studies, cells were incubated for
20 min with CK666, CK689, Blb(−), and Blb(+) compounds. In some experiments,
cell-free migration buffer containing inhibitors was superfused onto adherent cells.
Plasmin treatment of surfaces. Fibrin-cross-linked surfaces were seeded with pla-
telets and recorded for 15 min. Then, the platelet solution was replaced by modified
Tyrode’s buffer, and supplemented with calcium and plasmin (2.5 µg/ml) or H2O
(control group). Platelet behavior was recorded over time (45 min).
Immunostaining. For immunofluorescence studies, cells were fixated with PFA-GDA
(2%/0.05%) for 20min, and supplemented with NP40 (0.04%) for permeabilization.
Primary and secondary antibodies were subsequently added in PBS buffer containing
1% BSA for 45 min. Antibodies included CD41 (1:100) Arp2/3 complex (1:200), and
pMLC (1:200). Secondary antibodies and phalloidin–AlexaFluor 488 were added at a
concentration of 1:200. PAC-1 antibody (1:50) was added directly to migrating/
retracting platelets prior to fixation. Cells were assessed with an LSM 880 confocal
microscope (Carl Zeiss) in Airyscan mode (40/1.3 oil immers. obj.).
Time-lapse video microscopy. Differential interference contrast (DIC), phase-con-
trast, and epifluorescence movies (20 s/frame) were recorded on an automated
inverted Olympus IX83 microscope with an ×40/1.0 or ×100/1.4 oil-immersion
objective. The microscope was equipped with a stage incubator (37 °C, humidified,
Tokai Hit). For actin polymerization dynamics, LifeAct-eGFP platelets were
imaged with a frame rate of 6 s.
Plasmin treatment of surfaces. Fibrin-cross-linked surfaces were seeded with pla-
telets and recorded for 15 min. Then, the platelet solution was replaced by modified
Tyrode’s buffer, and supplemented with calcium and plasmin (2.5 µg/ml) or H2O
(control group). Platelet behavior was recorded over time (45 min).
Biofilm assessment. Coverslips were coated with monomeric fibrin (see Fibrin(ogen)
surface generation) for 15min. Fibrin surfaces were incubated with MRSA (1.4 ×
108 CFU/ml) labeled with CFSE (5 µM) for 30min at 37 °C and rinsed thoroughly
to remove non-adherent bacteria. Cells were activated, plated, and fixated as
described. For assessment of platelet recruitment, platelets were superfused on either
fibrinogen-coated slices incubated with MRSA or buffer without the addition of
ADP/U46619. Bacterial viability was tested after 45minutes by adding LIVE/DEAD
BacLight Bacterial Viability Kit (1.5 µl/ml) 15min before fixation
3D clot retraction. 3D clot retraction was assessed by adding AF488–fibrinogen
conjugate (15 µg/ml), Rhodamine 6G (0.0005%). and thrombin (1 U/ml) to PRP,
and clot retraction was imaged after 20 min on a LSM 880 confocal microscope in
AiryScan mode (×20/0.8 obj., 2× zoom for overviews, and 5× zoom for detailed
views, laser power: 0.96%)85. For inhibition experiments, the respective inhibitor
was added 20 min prior to the experiment.
In vitro platelet function assays
Activation flow cytometry. Washed platelets (2.5 × 105/µl) were diluted 1:24 in
modified Tyrode’s buffer, and activated by the addition of calcium (1 mM), and the
stated compounds86. For inhibition experiments, cells were preincubated with the
respective inhibitors for 20 min. At 5 min after activation, CD62P-APC and JonA-
PE were added. After 20 min, platelets were fixated by adding 1:4 cold PFA 4%.
Measurement was carried out on a BD Fortessa flow cytometer and analysis was
completed with FlowJo (V10).
Adhesion (in vitro thrombosis formation). Whole blood was incubated with Rho-
damine 6G to label platelets, recalcified, and perfused over a collagen-coated sur-
face at the arterial shear rate (1000/s) for 5 min87. Rhodamine 6G-covered area was
assessed by epifluorescence microscopy (Olympus IX83, ×40 objective).
Aggregation. Optical aggregometry was performed on PRP81. PRP was mixed with
modified Tyrode’s to obtain a platelet concentration of 1.5 × 105/µl. ADP (4 µM) or
collagen (0.1 mg/ml) were added under continuous stirring at 1000 r.p.m. at 37 °C
and measured in a two-channel aggregometer (ChronoLog 490-2D, Havertown,
USA). The percentage of maximal platelet aggregation was analyzed 6 min after the
addition of the agonist using Aggrolink software (ChronoLog, USA).
Clot retraction. PRP preincubated for 20 min with indicated inhibitors was recal-
cified, and 1 U/ml thrombin was added88. After 30 min incubation at 37 °C, clots
were photographed and the remaining fluid quantified to assess the degree of
retraction. As positive controls, we included cytochalasin D treatment completely
abrogating platelet function by blocking actin polymerization, and myosin II
blockade by blebbistatin(−).
Western blotting. Arp2/3 complex deletion was confirmed as described by Paul
et al.22, with minor variations. Obtained platelet pellets from Cre-positive and
-negative PF4cre-Arpc2fl/fl mice were homogenized in RIPA buffer containing
protease and phosphatase inhibitor cocktails (Thermo Fisher Scientific). Equal
amounts of total protein (50 mg) were subjected to western blot analysis.
Atomic force microscopy. Atomic force microscopy (AFM) images were acquired
according to the following protocol89: the mounted samples were attached to a
glass slide fitting into the microscope stage with silica gel and imaged with an MFP-
3D AFM (Asylum Research) and cantilevers of the MSNL Type (Type F, triangular,
Bruker) at 512 × 512 pixels in tapping mode in liquid. Overview scans (10 × 10
µm2) were acquired at a line rate of 0.25 Hz and representative 2 × 2 µm2 regions
were chosen for detailed views (line rate 0.5 Hz). Images were processed, and
sections were analyzed with Asylum AFM software and IGOR Pro (WaveMetrics).
Scanning electron microscopy. For scanning electron microscopy (SEM), cells
were incubated for 45 min in 0.1 M potassium-phosphate buffer containing 2.5%
GDA, and then dehydrated with ethanol. Before sputter coating of the surface with
gold (6 nm thickness, Cressington 108auto), a critical point dryer (Polaron E3000)
was used along with standard drying protocol. Probes were imaged on an LEO
DSM 982 SEM at 8 kV.
Data analysis. Data analysis was realized using FIJI90 (ImageJ), Imaris (Bitplane),
and ZenBlack (Zeiss). 4D in vivo data were stabilized with the ImageStabilizer
plugin and dimensions were reduced by MIP. Cells were tracked with Manual
tracking FIJI plugins. Tracks were further analyzed for velocity, directionality, and
distance using Chemotaxis Tool (Ibidi) plugin. Motility pattern was classified in
Rolling, defined as fast (>5 µm/min), directed movement in direction of flow,
leukocyte-dependent motility for platelets showing displacement and direct contact
with CD45+ leukocytes, adherence for platelets showing stable positioning over at
least three video frames without discernible displacement on the vessel wall, and
migration for repositioning of platelets on the vessel wall of more than one cell
diameter, without direct contact to CD45+ leukocytes. Cells were tracked in their
respective motility pattern for as long as they were visible in the recorded video.
Aggregated platelets were excluded from the analysis. In vitro tracking and shape
analysis of migrating and retracting platelets is described in detail elsewhere16.
Briefly, cells were manually counted in phase-contrast/difference interference
contrast, and cleared area was determined by using fluorescent fibrin(ogen) as
substrate, and thresholding the cleared area in the respective fluorescent channel.
For form analysis, cells were manually outlined, masked, and converted to binary
images. For quantification, FIJI shape descriptors and the Celltool suite were
used91. Distribution of subcellular proteins was assessed by drawing a line along the
cell’s shortest axis, defining front and rear. Resulting fluorescence profiles were
parceled in ten (1–10, front to rear) segments, and MFIs were calculated for each
region. Resulting MFIs were used to calculate averages across the cell population
for each defined segment. For Arp2/3 distribution analysis, lines were placed
adjacent to the pseudo-nucleus to avoid non-lamellipodial signal.
In biofilm experiments, bacteria size and percentage bundled by platelets were
determined by thresholding fluorescently labeled bacteria (CFSE) and platelets
(CD41-AF647), converting each channel to a binary image, and using FIJI
ImageCalculator plugin to determine overlap. Next, shape and size descriptors were
used to extract the parameters mentioned above. To assess bacterial viability, L/D-
stained biofilms were thresholded in GFP (all bacteria) and RFP (dead bacteria)
channels and percentages of non-viable bacteria were calculated. To determine the
spatial distribution of adherent/migrating platelets in respect to neutrophil
extravasation sites, we manually determined sites of neutrophil transmigration in
our processed videos of the cremaster microvasculature. Next, we performed a
SUM Projection of the time axis in the 649-channel visualizing platelets, defining
areas of prolonged platelet contact. Using the interaction analysis plugin
(MosaicIA), which performs an object-based interaction analysis in a spatial
statistics framework based on nearest-neighbor distance distributions92,93, we
determined the spatial correlation strength between both patterns. Statistical
significance was tested by F0 hypothesis testing. Colocalization of activated
integrins and fibrin(ogen) substrate in in vitro experiments was visualized with FIJI
plugin Coloc2. Data were post processed in Excel (Microsoft), Prism (GraphPad)
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and Illustrator (Adobe). 3D surface rendering and pseudo-coloring was performed
using Imaris (Bitplane).
Statistical analysis and reproducibility. Data are shown as means ± s.e.m. Sta-
tistical parameters, including the exact value of replicates (n) for individual
experiments, can be found within the figure legends. We predefined groups for
comparison prior to conducting the respective experiments. Representative data
shown in the figures were reproduced at least in three independent experiments.
For in vitro experiments, no prior statistical analyses to define sample sizes were
used. Instead, we based sample sizes on previous experiments in our lab and others.
Animal sample sizes were estimated using power calculations. To evaluate statis-
tical differences between groups, t tests, and analysis of variance (ANOVA) were
performed after testing for a normal distribution (F test or Kolmogorov–Smirnov
test). If data did not fulfill the criteria of normal distribution, Mann–Whitney or
Kruskal–Wallis tests were used, respectively. If ANOVA or Kruskal–Wallis tests
showed statistically significant differences between groups, we performed post hoc
tests (Tukey/Dunn’s, respectively). In matched-sample experiments, the paired t
test was used. Only two-sided testing was applied. To analyze contingency table
data, χ2 test was used. Survival was analyzed using the log-rank test. A p value of
<0.05 was considered statistically significant. Analyses were performed with Prism
(GraphPad Software) and Excel (Microsoft). Age- and sex-matched mice were used
for experiments. For adoptive transfer experiments, and hemorrhage assessment in
the cremaster, the researcher performing the analysis and quantification of data
was blinded to color allocation/genotype.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Data that support the findings of this study are available within the article and its
Supplementary information. Source data for all figures and Supplementary figures are
provided with the paper. Any additional information and related data are available upon
reasonable request.
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